Despite the majority of radiation oncologists administering the NCCN guideline-recommended thoracic radiotherapy schedule to patients with small-cell lung cancer, great variability still exists in dosing and fractionation.
Long-term data from a recent trial suggest that continuation of treatment with first-generation EGFR TKIs beyond EGFR-positive NSCLC progression does not improve overall survival.
A recent study compared the relative risk of cardiovascular ischemic events in patients with prostate cancer after surgical castration vs gonadotropin-releasing hormone agonist therapy.
A single-agent therapy provides durable remission rates and a high rate of peripheral neuropathy resolution in patients with relapsed or refractory systemic anaplastic large cell lymphoma.
Patients with cancer receiving radiation therapy who have a previous psychiatric diagnosis have 208% higher follow-up emergency department costs than patients without a pre-existing psychiatric diagnosis.
Approximately 40% of patients with rheumatoid arthritis with persistent moderate to high disease activity waited at least 90 days for adjustment of their DMARD therapy.
Nearly two-thirds of children and teens with terminal cancer receive intense care at the end of life, often in hospitals and intensive care units.
A real-life analysis compared multiple antidiabetic medications for increased risk of heart failure hospitalization.
A recent study found that 29% of breast cancer clinical trials are not comprised of control arms consistent with the current standard of care.
A recent study compared the effects of adjuvant chemotherapy and observation after preoperative chemoradiation and resection in gastroesophageal cancer.